PROCEPT BioRobotics Corporation (PRCT) Tops Q2 EPS by 1c

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q2 EPS of ($0.56), $0.01 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $33.1 million versus the consensus estimate of $30.31 million.

For earnings history and earnings-related data on PROCEPT BioRobotics Corporation (PRCT) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• MP Materials seen largely insulated after China export-control move